论文部分内容阅读
肾病综合征(NS)是原发性肾小球肾炎常见的临床症候群,表现为大量蛋白尿、低蛋白血症、高度水肿及高脂血症。治疗主要是以强的松为代表的肾上腺糖皮质激素类药物。阿赛松(化学名Triamcinolone,天津药业公司生产)是一种新型糖皮质激素制剂,为证实其疗效,我们将该药与强的松进行比较,进行随机对照研究。
Nephrotic syndrome (NS) is a common clinical syndrome of primary glomerulonephritis, manifested as a large number of proteinuria, hypoproteinemia, high degree of edema and hyperlipidemia. Treatment is mainly represented by prednisone glucocorticoid drugs. Asiason (chemical name Triamcinolone, manufactured by Tianjin Pharmaceutical Co., Ltd.) is a novel glucocorticoid preparation. To confirm its efficacy, we compared the drug with prednisone and conducted a randomized controlled study.